SE PUEDE YA AFIRMAR QUE TARLATAMAB ( IMDELLTRA BY AMGEN ) SUPERA AMPLIAMENTE AL LURBINECTEDIN ( ZEPZELCA BY PHARMAMAR ) TANTO EN PRIMERA LÍNEA DE MANTENIMIENTO ... COMO EN SEGUNDA LINEA PARA EL TRATAMIENTO ESTÁNDAR DE SMALL CELL LUNG CANCER EXTENSIVE-STAGE .
02 octubre 2020
Donald Trump : In Spain We Have an Antiviral Aplidin Capable of Ending COVID19 . Pharmamar Is The BioFarmaceuthical That Has Developed It and The Results of The Clinical Trial Are Very Close to Being Published . Post By Alcubi .
